首页 › 基金 › TRV GP VI, LLC › RAPP

TRV GP VI, LLC 对 RAPP 的持仓历史

RAPPORT THERAPEUTICS INC · 医疗保健

TRV GP VI, LLC 在 Q2 2026 的 13F 申报中披露持有 RAPP(RAPPORT THERAPEUTICS INC)969,218 股,市值约 US$40.4M,约占其申报组合的 17.39%,在其申报持仓中市值排名第 3 位。 TRV GP VI, LLC 最近 7 个申报季度中有 7 个季度披露了 RAPP 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q2 2026)969.22K 股
申报持仓市值$40.39M
组合权重17.39%
首次申报Q4 2024
最近变动持有
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

TRV GP VI, LLC 对 RAPP 的持仓演变

TRV GP VI, LLC 于 Q4 2024 首次披露 RAPP 持仓:969,218 股(约 US$17.2M)。 该持仓在 Q2 2026 达到峰值 969,218 股,市值约 US$40.4M。 在 7 次申报中,TRV GP VI, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 969,218 股、市值约 US$40.4M。

逐季持仓明细

季度股数金额变化
Q4 2024 969.22K $17.19M 新进
Q1 2025 969.22K $9.72M 持有
Q2 2025 969.22K $11.02M 持有
Q3 2025 969.22K $28.79M 持有
Q4 2025 969.22K $29.41M 持有
Q1 2026 969.22K $30.33M 持有
Q2 2026 969.22K $40.39M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RAPP 与 13F 数据

RAPP(RAPPORT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 RAPP,申报仓位最大的包括:TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RAPP 的基金

查看 RAPP 的全部基金持有人 →

常见问题

How long has TRV GP VI, LLC held RAPP?

TRV GP VI, LLC has disclosed RAPP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is TRV GP VI, LLC's current position in RAPP?

As of Q2 2026, TRV GP VI, LLC holds 969.22K shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $40.39M, representing 17.39% of its reported portfolio and ranking #3.

Has TRV GP VI, LLC been buying or selling RAPP?

In the latest 13F filing (Q2 2026), TRV GP VI, LLC held unchanged its position in RAPP. The position peaked in Q2 2026 at 969.22K shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.